1. Home
  2. CPRX vs VTMX Comparison

CPRX vs VTMX Comparison

Compare CPRX & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • VTMX
  • Stock Information
  • Founded
  • CPRX 2002
  • VTMX 1998
  • Country
  • CPRX United States
  • VTMX Mexico
  • Employees
  • CPRX N/A
  • VTMX N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • VTMX
  • Sector
  • CPRX Health Care
  • VTMX
  • Exchange
  • CPRX Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • CPRX 2.6B
  • VTMX 2.3B
  • IPO Year
  • CPRX 2006
  • VTMX 2023
  • Fundamental
  • Price
  • CPRX $19.83
  • VTMX $28.51
  • Analyst Decision
  • CPRX Strong Buy
  • VTMX Sell
  • Analyst Count
  • CPRX 6
  • VTMX 2
  • Target Price
  • CPRX $32.83
  • VTMX $29.50
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • VTMX 155.8K
  • Earning Date
  • CPRX 08-06-2025
  • VTMX 07-24-2025
  • Dividend Yield
  • CPRX N/A
  • VTMX 2.30%
  • EPS Growth
  • CPRX 183.96
  • VTMX N/A
  • EPS
  • CPRX 1.65
  • VTMX 0.04
  • Revenue
  • CPRX $558,499,000.00
  • VTMX $263,061,301.00
  • Revenue This Year
  • CPRX $16.37
  • VTMX $15.37
  • Revenue Next Year
  • CPRX $8.80
  • VTMX $11.02
  • P/E Ratio
  • CPRX $11.91
  • VTMX $71.83
  • Revenue Growth
  • CPRX 28.55
  • VTMX 11.49
  • 52 Week Low
  • CPRX $16.06
  • VTMX $21.30
  • 52 Week High
  • CPRX $26.58
  • VTMX $30.73
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 37.75
  • VTMX 66.37
  • Support Level
  • CPRX $19.15
  • VTMX $25.28
  • Resistance Level
  • CPRX $22.53
  • VTMX $28.78
  • Average True Range (ATR)
  • CPRX 0.73
  • VTMX 0.67
  • MACD
  • CPRX -0.03
  • VTMX 0.24
  • Stochastic Oscillator
  • CPRX 24.26
  • VTMX 92.14

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: